放射性医薬品のグローバル市場 2021年：企業別、地域別、種類・用途別

• 英文タイトル：Global Radiopharmaceuticals Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

• レポートコード：GIR-203B16324 • 出版社/出版日：GlobalInfoResearch / 2021年12月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥522,000 (USD3,480)	▷ お問い合わせ
Multi User	￥783,000 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,044,000 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

放射性医薬品市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 GlobalInfoResearchの最新の調査によると、世界の放射性医薬品の市場規模は2020年のxxx米ドルから2021年にはxxx米ドルと推定され、2020年から2021年の間にxxx％の変化があります。世界の放射性医薬品の市場規模は次の5年間でxxx％のCAGRで成長すると予想されます。 放射性医薬品市場は種類と用途によって区分されます。2016年～2026年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメントは次をカバーします。 ・診断用放射性同位元素、治療用放射性同位元素 用途別セグメントは次のように区分されます。 ・腫瘍学、心臓病学、その他 世界の放射性医薬品市場の主要な市場プレーヤーは以下のとおりです。 ・Bracco Imaging、Bayer、Mallinckrodt、Nordion、Triad Isotopes、Lantheus、IBA Group、GE Healthcare、China Isotope & Radiation、Jubilant Pharma、Eli Lilly、Advanced Accelerator Applications、SIEMENS、Dongcheng、Navidea 地域別セグメントは次の地域・国をカバーします。 ・北米（米国、カナダ、メキシコ） ・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南アメリカ（ブラジル、アルゼンチン、コロンビア） ・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計14章あります。 ・第1章では、放射性医薬品製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要な放射性医薬品メーカーの企業概要、2019年～2021年までの放射性医薬品の価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要な放射性医薬品メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2016年～2026年までの地域別放射性医薬品の販売量、売上、成長性を示しています。 ・第5、6章では、2016年～2026年までの放射性医薬品の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2016年～2021年までの世界の主要国での販売量、売上、市場シェア、並びに2021年～2026年までの主要地域での放射性医薬品市場予測を収録しています。 ・第12、13、14章では、放射性医薬品の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 ・メーカー情報（企業概要、製品概要、販売量、価格、売上）：Bracco Imaging、Bayer、Mallinckrodt、Nordion、Triad Isotopes、Lantheus、IBA Group、GE Healthcare、China Isotope & Radiation、Jubilant Pharma、Eli Lilly、Advanced Accelerator Applications、SIEMENS、Dongcheng、Navidea ・メーカー別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：診断用放射性同位元素、治療用放射性同位元素 ・用途別分析2016年-2026年：腫瘍学、心臓病学、その他 ・放射性医薬品の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・放射性医薬品のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・放射性医薬品のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・放射性医薬品の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・放射性医薬品の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Radiopharmaceuticals market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Radiopharmaceuticals size is estimated to be XX million in 2021 from USD 6441.3 million in 2020, with a change of XX% between 2020 and 2021. The global Radiopharmaceuticals market size is expected to grow at a CAGR of 7.7% for the next five years.

Market segmentation
Radiopharmaceuticals market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Diagnostic Radioisotopes
Therapeutic Radioisotopes

Market segment by Application can be divided into
Oncology
Cardiology
Other

The key market players for global Radiopharmaceuticals market are listed below:
Bracco Imaging
Bayer
Mallinckrodt
Nordion
Triad Isotopes
Lantheus
IBA Group
GE Healthcare
China Isotope & Radiation
Jubilant Pharma
Eli Lilly
Advanced Accelerator Applications
SIEMENS
Dongcheng
Navidea

Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Radiopharmaceuticals product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Radiopharmaceuticals, with price, sales, revenue and global market share of Radiopharmaceuticals from 2019 to 2021.
Chapter 3, the Radiopharmaceuticals competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Radiopharmaceuticals breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Radiopharmaceuticals market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Radiopharmaceuticals sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

---

1 Market Overview
1.1 Radiopharmaceuticals Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Radiopharmaceuticals Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Diagnostic Radioisotopes
1.2.3 Therapeutic Radioisotopes
1.3 Market Analysis by Application
1.3.1 Overview: Global Radiopharmaceuticals Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Oncology
1.3.3 Cardiology
1.3.4 Other
1.4 Global Radiopharmaceuticals Market Size & Forecast
1.4.1 Global Radiopharmaceuticals Sales in Value (2016-2026))
1.4.2 Global Radiopharmaceuticals Sales in Volume (2016-2026)
1.4.3 Global Radiopharmaceuticals Price by Type (2016-2026) & (US$/Dose)
1.5 Global Radiopharmaceuticals Production Capacity Analysis
1.5.1 Global Radiopharmaceuticals Total Production Capacity (2016-2026)
1.5.2 Global Radiopharmaceuticals Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Radiopharmaceuticals Market Drivers
1.6.2 Radiopharmaceuticals Market Restraints
1.6.3 Radiopharmaceuticals Trends Analysis
2 Manufacturers Profiles
2.1 Bracco Imaging
2.1.1 Bracco Imaging Details
2.1.2 Bracco Imaging Major Business
2.1.3 Bracco Imaging Radiopharmaceuticals Product and Services
2.1.4 Bracco Imaging Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Bayer
2.2.1 Bayer Details
2.2.2 Bayer Major Business
2.2.3 Bayer Radiopharmaceuticals Product and Services
2.2.4 Bayer Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Mallinckrodt
2.3.1 Mallinckrodt Details
2.3.2 Mallinckrodt Major Business
2.3.3 Mallinckrodt Radiopharmaceuticals Product and Services
2.3.4 Mallinckrodt Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Nordion
2.4.1 Nordion Details
2.4.2 Nordion Major Business
2.4.3 Nordion Radiopharmaceuticals Product and Services
2.4.4 Nordion Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Triad Isotopes
2.5.1 Triad Isotopes Details
2.5.2 Triad Isotopes Major Business
2.5.3 Triad Isotopes Radiopharmaceuticals Product and Services
2.5.4 Triad Isotopes Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Lantheus
2.6.1 Lantheus Details
2.6.2 Lantheus Major Business
2.6.3 Lantheus Radiopharmaceuticals Product and Services
2.6.4 Lantheus Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 IBA Group
2.7.1 IBA Group Details
2.7.2 IBA Group Major Business
2.7.3 IBA Group Radiopharmaceuticals Product and Services
2.7.4 IBA Group Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 GE Healthcare
2.8.1 GE Healthcare Details
2.8.2 GE Healthcare Major Business
2.8.3 GE Healthcare Radiopharmaceuticals Product and Services
2.8.4 GE Healthcare Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 China Isotope & Radiation
2.9.1 China Isotope & Radiation Details
2.9.2 China Isotope & Radiation Major Business
2.9.3 China Isotope & Radiation Radiopharmaceuticals Product and Services
2.9.4 China Isotope & Radiation Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 Jubilant Pharma
2.10.1 Jubilant Pharma Details
2.10.2 Jubilant Pharma Major Business
2.10.3 Jubilant Pharma Radiopharmaceuticals Product and Services
2.10.4 Jubilant Pharma Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.11 Eli Lilly
2.11.1 Eli Lilly Details
2.11.2 Eli Lilly Major Business
2.11.3 Eli Lilly Radiopharmaceuticals Product and Services
2.11.4 Eli Lilly Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.12 Advanced Accelerator Applications
2.12.1 Advanced Accelerator Applications Details
2.12.2 Advanced Accelerator Applications Major Business
2.12.3 Advanced Accelerator Applications Radiopharmaceuticals Product and Services
2.12.4 Advanced Accelerator Applications Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.13 SIEMENS
2.13.1 SIEMENS Details
2.13.2 SIEMENS Major Business
2.13.3 SIEMENS Radiopharmaceuticals Product and Services
2.13.4 SIEMENS Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.14 Dongcheng
2.14.1 Dongcheng Details
2.14.2 Dongcheng Major Business
2.14.3 Dongcheng Radiopharmaceuticals Product and Services
2.14.4 Dongcheng Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.15 Navidea
2.15.1 Navidea Details
2.15.2 Navidea Major Business
2.15.3 Navidea Radiopharmaceuticals Product and Services
2.15.4 Navidea Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Radiopharmaceuticals Sales by Manufacturer
3.1 Global Radiopharmaceuticals Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Radiopharmaceuticals Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Radiopharmaceuticals
3.4 Market Concentration Rate
3.4.1 Top 3 Radiopharmaceuticals Manufacturer Market Share
3.4.2 Top 6 Radiopharmaceuticals Manufacturer Market Share
3.5 Global Radiopharmaceuticals Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Radiopharmaceuticals Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Radiopharmaceuticals Market Size by Region
4.1.1 Global Radiopharmaceuticals Sales in Volume by Region (2016-2026)
4.1.2 Global Radiopharmaceuticals Revenue by Region (2016-2026)
4.2 North America Radiopharmaceuticals Revenue (2016-2026)
4.3 Europe Radiopharmaceuticals Revenue (2016-2026)
4.4 Asia-Pacific Radiopharmaceuticals Revenue (2016-2026)
4.5 South America Radiopharmaceuticals Revenue (2016-2026)
4.6 Middle East and Africa Radiopharmaceuticals Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Radiopharmaceuticals Sales in Volume by Type (2016-2026)
5.2 Global Radiopharmaceuticals Revenue by Type (2016-2026)
5.3 Global Radiopharmaceuticals Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Radiopharmaceuticals Sales in Volume by Application (2016-2026)
6.2 Global Radiopharmaceuticals Revenue by Application (2016-2026)
6.3 Global Radiopharmaceuticals Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Radiopharmaceuticals Sales by Type (2016-2026)
7.2 North America Radiopharmaceuticals Sales by Application (2016-2026)
7.3 North America Radiopharmaceuticals Market Size by Country
7.3.1 North America Radiopharmaceuticals Sales in Volume by Country (2016-2026)
7.3.2 North America Radiopharmaceuticals Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Radiopharmaceuticals Sales by Type (2016-2026)
8.2 Europe Radiopharmaceuticals Sales by Application (2016-2026)
8.3 Europe Radiopharmaceuticals Market Size by Country
8.3.1 Europe Radiopharmaceuticals Sales in Volume by Country (2016-2026)
8.3.2 Europe Radiopharmaceuticals Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Radiopharmaceuticals Sales by Type (2016-2026)
9.2 Asia-Pacific Radiopharmaceuticals Sales by Application (2016-2026)
9.3 Asia-Pacific Radiopharmaceuticals Market Size by Region
9.3.1 Asia-Pacific Radiopharmaceuticals Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Radiopharmaceuticals Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Radiopharmaceuticals Sales by Type (2016-2026)
10.2 South America Radiopharmaceuticals Sales by Application (2016-2026)
10.3 South America Radiopharmaceuticals Market Size by Country
10.3.1 South America Radiopharmaceuticals Sales in Volume by Country (2016-2026)
10.3.2 South America Radiopharmaceuticals Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Radiopharmaceuticals Sales by Type (2016-2026)
11.2 Middle East & Africa Radiopharmaceuticals Sales by Application (2016-2026)
11.3 Middle East & Africa Radiopharmaceuticals Market Size by Country
11.3.1 Middle East & Africa Radiopharmaceuticals Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Radiopharmaceuticals Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Radiopharmaceuticals Typical Distributors
12.3 Radiopharmaceuticals Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

List of Tables
Table 1. Global Radiopharmaceuticals Revenue by Type, (USD Million), 2021-2026
Table 2. Global Radiopharmaceuticals Revenue by Application, (USD Million), 2021-2026
Table 3. Bracco Imaging Basic Information, Manufacturing Base and Competitors
Table 4. Bracco Imaging Major Business
Table 5. Bracco Imaging Radiopharmaceuticals Product and Services
Table 6. Bracco Imaging Radiopharmaceuticals Sales (K Dose), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Bayer Basic Information, Manufacturing Base and Competitors
Table 8. Bayer Major Business
Table 9. Bayer Radiopharmaceuticals Product and Services
Table 10. Bayer Radiopharmaceuticals Sales (K Dose), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Mallinckrodt Basic Information, Manufacturing Base and Competitors
Table 12. Mallinckrodt Major Business
Table 13. Mallinckrodt Radiopharmaceuticals Product and Services
Table 14. Mallinckrodt Radiopharmaceuticals Sales (K Dose), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Nordion Basic Information, Manufacturing Base and Competitors
Table 16. Nordion Major Business
Table 17. Nordion Radiopharmaceuticals Product and Services
Table 18. Nordion Radiopharmaceuticals Sales (K Dose), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Triad Isotopes Basic Information, Manufacturing Base and Competitors
Table 20. Triad Isotopes Major Business
Table 21. Triad Isotopes Radiopharmaceuticals Product and Services
Table 22. Triad Isotopes Radiopharmaceuticals Sales (K Dose), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Lantheus Basic Information, Manufacturing Base and Competitors
Table 24. Lantheus Major Business
Table 25. Lantheus Radiopharmaceuticals Product and Services
Table 26. Lantheus Radiopharmaceuticals Sales (K Dose), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. IBA Group Basic Information, Manufacturing Base and Competitors
Table 28. IBA Group Major Business
Table 29. IBA Group Radiopharmaceuticals Product and Services
Table 30. IBA Group Radiopharmaceuticals Sales (K Dose), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. GE Healthcare Basic Information, Manufacturing Base and Competitors
Table 32. GE Healthcare Major Business
Table 33. GE Healthcare Radiopharmaceuticals Product and Services
Table 34. GE Healthcare Radiopharmaceuticals Sales (K Dose), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. China Isotope & Radiation Basic Information, Manufacturing Base and Competitors
Table 36. China Isotope & Radiation Major Business
Table 37. China Isotope & Radiation Radiopharmaceuticals Product and Services
Table 38. China Isotope & Radiation Radiopharmaceuticals Sales (K Dose), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Jubilant Pharma Basic Information, Manufacturing Base and Competitors
Table 40. Jubilant Pharma Major Business
Table 41. Jubilant Pharma Radiopharmaceuticals Product and Services
Table 42. Jubilant Pharma Radiopharmaceuticals Sales (K Dose), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 44. Eli Lilly Major Business
Table 45. Eli Lilly Radiopharmaceuticals Product and Services
Table 46. Eli Lilly Radiopharmaceuticals Sales (K Dose), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Advanced Accelerator Applications Basic Information, Manufacturing Base and Competitors
Table 48. Advanced Accelerator Applications Major Business
Table 49. Advanced Accelerator Applications Radiopharmaceuticals Product and Services
Table 50. Advanced Accelerator Applications Radiopharmaceuticals Sales (K Dose), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. SIEMENS Basic Information, Manufacturing Base and Competitors
Table 52. SIEMENS Major Business
Table 53. SIEMENS Radiopharmaceuticals Product and Services
Table 54. SIEMENS Radiopharmaceuticals Sales (K Dose), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. Dongcheng Basic Information, Manufacturing Base and Competitors
Table 56. Dongcheng Major Business
Table 57. Dongcheng Radiopharmaceuticals Product and Services
Table 58. Dongcheng Radiopharmaceuticals Sales (K Dose), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 59. Navidea Basic Information, Manufacturing Base and Competitors
Table 60. Navidea Major Business
Table 61. Navidea Radiopharmaceuticals Product and Services
Table 62. Navidea Radiopharmaceuticals Sales (K Dose), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 63. Global Radiopharmaceuticals Sales by Manufacturer (2019-2021e) & (K Dose)
Table 64. Global Radiopharmaceuticals Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 65. Market Position of Manufacturers in Radiopharmaceuticals, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 66. Global Radiopharmaceuticals Production Capacity by Company, (K Dose): 2020 VS 2021
Table 67. Head Office and Radiopharmaceuticals Production Site of Key Manufacturer
Table 68. Radiopharmaceuticals New Entrant and Capacity Expansion Plans
Table 69. Radiopharmaceuticals Mergers & Acquisitions in the Past Five Years
Table 70. Global Radiopharmaceuticals Sales by Region (2016-2021e) & (K Dose)
Table 71. Global Radiopharmaceuticals Sales by Region (2021-2026) & (K Dose)
Table 72. Global Radiopharmaceuticals Revenue by Region (2016-2021e) & (USD Million)
Table 73. Global Radiopharmaceuticals Revenue by Region (2021-2026) & (USD Million)
Table 74. Global Radiopharmaceuticals Sales by Type (2016-2021e) & (K Dose)
Table 75. Global Radiopharmaceuticals Sales by Type (2021-2026) & (K Dose)
Table 76. Global Radiopharmaceuticals Revenue by Type (2016-2021e) & (USD Million)
Table 77. Global Radiopharmaceuticals Revenue by Type (2021-2026) & (USD Million)
Table 78. Global Radiopharmaceuticals Price by Type (2016-2021e) & (US$/Dose)
Table 79. Global Radiopharmaceuticals Price by Type (2021-2026) & (US$/Dose)
Table 80. Global Radiopharmaceuticals Sales by Application (2016-2021e) & (K Dose)
Table 81. Global Radiopharmaceuticals Sales by Application (2021-2026) & (K Dose)
Table 82. Global Radiopharmaceuticals Revenue by Application (2016-2021e) & (USD Million)
Table 83. Global Radiopharmaceuticals Revenue by Application (2021-2026) & (USD Million)
Table 84. Global Radiopharmaceuticals Price by Application (2016-2021e) & (US$/Dose)
Table 85. Global Radiopharmaceuticals Price by Application (2021-2026) & (US$/Dose)
Table 86. North America Radiopharmaceuticals Sales by Country (2016-2021e) & (K Dose)
Table 87. North America Radiopharmaceuticals Sales by Country (2021-2026) & (K Dose)
Table 88. North America Radiopharmaceuticals Revenue by Country (2016-2021e) & (USD Million)
Table 89. North America Radiopharmaceuticals Revenue by Country (2021-2026) & (USD Million)
Table 90. North America Radiopharmaceuticals Sales by Type (2016-2021e) & (K Dose)
Table 91. North America Radiopharmaceuticals Sales by Type (2021-2026) & (K Dose)
Table 92. North America Radiopharmaceuticals Sales by Application (2016-2021e) & (K Dose)
Table 93. North America Radiopharmaceuticals Sales by Application (2021-2026) & (K Dose)
Table 94. Europe Radiopharmaceuticals Sales by Country (2016-2021e) & (K Dose)
Table 95. Europe Radiopharmaceuticals Sales by Country (2021-2026) & (K Dose)
Table 96. Europe Radiopharmaceuticals Revenue by Country (2016-2021e) & (USD Million)
Table 97. Europe Radiopharmaceuticals Revenue by Country (2021-2026) & (USD Million)
Table 98. Europe Radiopharmaceuticals Sales by Type (2016-2021e) & (K Dose)
Table 99. Europe Radiopharmaceuticals Sales by Type (2021-2026) & (K Dose)
Table 100. Europe Radiopharmaceuticals Sales by Application (2016-2021e) & (K Dose)
Table 101. Europe Radiopharmaceuticals Sales by Application (2021-2026) & (K Dose)
Table 102. Asia-Pacific Radiopharmaceuticals Sales by Region (2016-2021e) & (K Dose)
Table 103. Asia-Pacific Radiopharmaceuticals Sales by Region (2021-2026) & (K Dose)
Table 104. Asia-Pacific Radiopharmaceuticals Revenue by Region (2016-2021e) & (USD Million)
Table 105. Asia-Pacific Radiopharmaceuticals Revenue by Region (2021-2026) & (USD Million)
Table 106. Asia-Pacific Radiopharmaceuticals Sales by Type (2016-2021e) & (K Dose)
Table 107. Asia-Pacific Radiopharmaceuticals Sales by Type (2021-2026) & (K Dose)
Table 108. Asia-Pacific Radiopharmaceuticals Sales by Application (2016-2021e) & (K Dose)
Table 109. Asia-Pacific Radiopharmaceuticals Sales by Application (2021-2026) & (K Dose)
Table 110. South America Radiopharmaceuticals Sales by Country (2016-2021e) & (K Dose)
Table 111. South America Radiopharmaceuticals Sales by Country (2021-2026) & (K Dose)
Table 112. South America Radiopharmaceuticals Revenue by Country (2016-2021e) & (USD Million)
Table 113. South America Radiopharmaceuticals Revenue by Country (2021-2026) & (USD Million)
Table 114. South America Radiopharmaceuticals Sales by Type (2016-2021e) & (K Dose)
Table 115. South America Radiopharmaceuticals Sales by Type (2021-2026) & (K Dose)
Table 116. South America Radiopharmaceuticals Sales by Application (2016-2021e) & (K Dose)
Table 117. South America Radiopharmaceuticals Sales by Application (2021-2026) & (K Dose)
Table 118. Middle East & Africa Radiopharmaceuticals Sales by Country (2016-2021e) & (K Dose)
Table 119. Middle East & Africa Radiopharmaceuticals Sales by Country (2021-2026) & (K Dose)
Table 120. Middle East & Africa Radiopharmaceuticals Revenue by Country (2016-2021e) & (USD Million)
Table 121. Middle East & Africa Radiopharmaceuticals Revenue by Country (2021-2026) & (USD Million)
Table 122. Middle East & Africa Radiopharmaceuticals Sales by Type (2016-2021e) & (K Dose)
Table 123. Middle East & Africa Radiopharmaceuticals Sales by Type (2021-2026) & (K Dose)
Table 124. Middle East & Africa Radiopharmaceuticals Sales by Application (2016-2021e) & (K Dose)
Table 125. Middle East & Africa Radiopharmaceuticals Sales by Application (2021-2026) & (K Dose)
Table 126. Direct Channel Pros & Cons
Table 127. Indirect Channel Pros & Cons
Table 128. Radiopharmaceuticals Typical Distributors
Table 129. Radiopharmaceuticals Typical Customers
List of Figures
Figure 1. Radiopharmaceuticals Picture
Figure 2. Global Radiopharmaceuticals Sales Market Share by Type in 2020
Figure 3. Diagnostic Radioisotopes
Figure 4. Therapeutic Radioisotopes
Figure 5. Global Radiopharmaceuticals Sales Market Share by Application in 2020
Figure 6. Oncology
Figure 7. Cardiology
Figure 8. Other
Figure 9. Global Radiopharmaceuticals Market Size, (USD Million) & (K Dose): 2020 VS 2021 VS 2026
Figure 10. Global Radiopharmaceuticals Market Size and Forecast (2016-2026) & (USD Million)
Figure 11. Global Radiopharmaceuticals Sales (2016-2026) & (K Dose)
Figure 12. Global Radiopharmaceuticals Price by Type (2016-2026) & (US$/Dose)
Figure 13. Global Radiopharmaceuticals Production Capacity (2016-2026) & (K Dose)
Figure 14. Global Radiopharmaceuticals Production Capacity by Geographic Region: 2020 VS 2021
Figure 15. Radiopharmaceuticals Market Drivers
Figure 16. Radiopharmaceuticals Market Restraints
Figure 17. Radiopharmaceuticals Market Trends
Figure 18. Global Radiopharmaceuticals Sales Market Share by Manufacturer in 2020
Figure 19. Global Radiopharmaceuticals Revenue Market Share by Manufacturer in 2020
Figure 20. Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 21. Top 3 Radiopharmaceuticals Manufacturer (Revenue) Market Share in 2020
Figure 22. Top 6 Radiopharmaceuticals Manufacturer (Revenue) Market Share in 2020
Figure 23. Global Radiopharmaceuticals Sales Market Share by Region (2016-2026)
Figure 24. Global Radiopharmaceuticals Revenue Market Share by Region (2016-2026)
Figure 25. North America Radiopharmaceuticals Revenue (2016-2026) & (USD Million)
Figure 26. Europe Radiopharmaceuticals Revenue (2016-2026) & (USD Million)
Figure 27. Asia-Pacific Radiopharmaceuticals Revenue (2016-2026) & (USD Million)
Figure 28. South America Radiopharmaceuticals Revenue (2016-2026) & (USD Million)
Figure 29. Middle East & Africa Radiopharmaceuticals Revenue (2016-2026) & (USD Million)
Figure 30. Global Radiopharmaceuticals Sales Market Share by Type (2016-2026)
Figure 31. Global Radiopharmaceuticals Revenue Market Share by Type (2016-2026)
Figure 32. Global Radiopharmaceuticals Price by Type (2016-2026) & (US$/Dose)
Figure 33. Global Radiopharmaceuticals Sales Market Share by Application (2016-2026)
Figure 34. Global Radiopharmaceuticals Revenue Market Share by Application (2016-2026)
Figure 35. Global Radiopharmaceuticals Price by Application (2016-2026) & (US$/Dose)
Figure 36. North America Radiopharmaceuticals Sales Market Share by Type (2016-2026)
Figure 37. North America Radiopharmaceuticals Sales Market Share by Application (2016-2026)
Figure 38. North America Radiopharmaceuticals Sales Market Share by Country (2016-2026)
Figure 39. North America Radiopharmaceuticals Revenue Market Share by Country (2016-2026)
Figure 40. United States Radiopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 41. Canada Radiopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Mexico Radiopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Europe Radiopharmaceuticals Sales Market Share by Type (2016-2026)
Figure 44. Europe Radiopharmaceuticals Sales Market Share by Application (2016-2026)
Figure 45. Europe Radiopharmaceuticals Sales Market Share by Country (2016-2026)
Figure 46. Europe Radiopharmaceuticals Revenue Market Share by Country (2016-2026)
Figure 47. Germany Radiopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. France Radiopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. United Kingdom Radiopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Russia Radiopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Italy Radiopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Asia-Pacific Radiopharmaceuticals Sales Market Share by Region (2016-2026)
Figure 53. Asia-Pacific Radiopharmaceuticals Sales Market Share by Application (2016-2026)
Figure 54. Asia-Pacific Radiopharmaceuticals Sales Market Share by Region (2016-2026)
Figure 55. Asia-Pacific Radiopharmaceuticals Revenue Market Share by Region (2016-2026)
Figure 56. China Radiopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Japan Radiopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Korea Radiopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. India Radiopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Southeast Asia Radiopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Australia Radiopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. South America Radiopharmaceuticals Sales Market Share by Type (2016-2026)
Figure 63. South America Radiopharmaceuticals Sales Market Share by Application (2016-2026)
Figure 64. South America Radiopharmaceuticals Sales Market Share by Country (2016-2026)
Figure 65. South America Radiopharmaceuticals Revenue Market Share by Country (2016-2026)
Figure 66. Brazil Radiopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Argentina Radiopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Middle East & Africa Radiopharmaceuticals Sales Market Share by Type (2016-2026)
Figure 69. Middle East & Africa Radiopharmaceuticals Sales Market Share by Application (2016-2026)
Figure 70. Middle East & Africa Radiopharmaceuticals Sales Market Share by Country (2016-2026)
Figure 71. Middle East & Africa Radiopharmaceuticals Revenue Market Share by Country (2016-2026)
Figure 72. Turkey Radiopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Egypt Radiopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Saudi Arabia Radiopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. South Africa Radiopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel
Figure 77. Methodology
Figure 78. Research Process and Data Source

---